Earnings Breakdown: Heron Therapeutics Q4
Benzinga Insights 8 months ago
Earnings
Heron Therapeutics (NASDAQ:HRTX) announced its Q4 earnings on Thursday, February 26, 2026 at 07:45 AM.
Here's a breakdown of the earnings report.
Earnings
Heron Therapeutics beat estimated earnings by 33.33%, reporting an EPS of $-0.02 versus an estimate of $-0.03.
Revenue was down $193 thousand from the same period last year.
Performance in Previous Earnings
The company missed on EPS by $0.02 in the last quarter, resulting in a 2.63% drop share price change the following day.
Here's a look at Heron Therapeutics's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.02 | -0.01 | -0.01 | -0.03 |
| EPS Actual | -0.04 | -0.02 | 0.01 | 0.02 |
| Revenue Estimate | 38.85M | 38.01M | 37.42M | 37.37M |
| Revenue Actual | 38.21M | 37.20M | 38.90M | 40.78M |
To track all earnings releases for Heron Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.